🌿 Environment 1d ago · BioPharma Dive staff

Teva claims success in celiac study; BioMarin, Ascendis settle patent dispute

BioPharma Dive
BioPharma industry news
View Channel →
Teva claims success in celiac study; BioMarin, Ascendis settle patent dispute
Source ↗ 👁 0 💬 0
Teva believes the therapy has “pipeline-in-a-product” potential. Elsewhere, a high-stakes trial was paused and GSK advanced a competitor to Moderna’s flu shot.

Comments (0)

Sign in to join the discussion

More Like This

How cities can use rain gardens to help prevent flooding
Earth News - Earth Science News, Earth Science, Climate Change · 5h ago
Food waste collection for multifamily housing expands in D.C.
Smart Cities Dive - Latest News · 5h ago
📰
Ridership up, crime down on LA Metro transit system
Smart Cities Dive - Latest News · 5h ago
NovoCure says cyberattack caused patient data exposure
MedTech Dive - Latest News · 5h ago
Scientists race to measure wildfire damage to UK soils
Earth News - Earth Science News, Earth Science, Climate Change · 5h ago
Repeal of U.S. Roadless Rule could threaten drinking water for 25 million people
Conservation news · 5h ago